ClinicalTrials.Veeva

Menu

Intraoperative Echocardiography in Low-Risk CABG Surgery

University of Pennsylvania logo

University of Pennsylvania

Status

Active, not recruiting

Conditions

Stenosis Coronary
Coronary Artery Disease
Chest Pain
STEMI
Heart Diseases

Treatments

Device: TEE probe

Study type

Interventional

Funder types

Other
NIH

Identifiers

Details and patient eligibility

About

This goal of this study is to better understand when and where intraoperative transesophageal echocardiography (TEE) should (or should not) be used during coronary artery bypass graft (CABG) surgeries.

Full description

This trial will look at benefits and harms to two different treatments strategies in order to improve clinical outcomes. Intraoperative TEE is an ultrasound-based, imaging device that uses sound valves to look at the heart continuously during a heart surgery.

Enrollment

40 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Scheduled to undergo isolated CABG surgery at a hospital within the UPenn Health System
  2. Age ≥18 years
  3. Ejection fraction ≥50%
  4. Transthoracic echocardiography within one year of scheduled surgery date
  5. Left heart catheterization within one year of scheduled surgery date
  6. English language fluency or facilitated via language interpreter
  7. Able to provide informed consent either in English or via a language interpreter
  8. Willing to comply with all study procedures

Exclusion criteria

  1. Documented valve (aortic, mitral, tricuspid, or pulmonic) disease (stenosis or regurgitation) moderate or greater.

  2. Any CABG surgery with either "possible" or "definite" aortic intervention listed as a planned part of the procedure. plan for either definite or possible surgical intervention.

  3. Any CABG surgery with either "possible" or "definite" valve repair/replacement listed as a planned part of the procedure.

  4. Having undergone any previous cardiac surgeries (i.e. scheduled with a "REDO" modifier).

  5. Proximal/critical left main coronary disease (e.g. greater than or equal to 90% stenosis).

  6. Preexisting anomalous coronary arteries

  7. Preexisting end-stage renal disease on hemodialysis

  8. Preexisting chronic kidney disease (CKD) stage 3, 4, or 5

  9. Stroke with residual focal neurological deficit(s) within 90 days of surgery

  10. Any of the following presurgical, mechanical circulatory support devices:

    1. Intraaortic balloon pump
    2. Percutaneous right ventricular assist device (RVAD)
    3. Impella
    4. Extracorporeal membrane oxygenation (ECMO)
  11. Absolute contraindication to echocardiography defined as one or more of the following documented conditions:

    1. Esophagectomy
    2. Esophagogastrectomy
    3. Esophageal trauma
  12. Any of these three relative contraindication to TEE:

    1. Esophageal varies
    2. Gastric bypass surgery
    3. Descending thoracic aortic aneurysm
  13. Severe pulmonary hypertension defined as:

    1. Pulmonary arterial pressure ≥60 mmHg
    2. Pulmonary vascular resistance (PVR) ≥3 Woods Units
  14. Hemodynamic instability after induction and following placement of an endotracheal tube will be defined as one or more of the following events or scenarios:

    1. Placement of an intraaortic balloon pump (IABP)
    2. Initiation of venoarterial extracorporeal membrane oxygenation (VAECMO)
    3. Placement of a right or left percutaneous mechanical circulatory support device
    4. Initiation of epinephrine infusion at a dose ≥ 6 mcg/min for a duration ≥5 minutes
    5. Initiation of norepinephrine at a dose ≥8 mcg/min for a duration ≥ minutes
    6. Initiation of phenylephrine infusion at a dose ≥100 mcg/min for a duration ≥ minutes
    7. Initiation of vasopressin infusion at a dose ≥0.04 units/min for a duration ≥ minutes

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Default TEE
Active Comparator group
Description:
The TEE probe is placed after going under general anesthesia and a breathing tube is placed. TEE issued to take pictures of the heart before and after a CABG surgery. If randomized to this group, the TEE probe will remain in place throughout the surgery.
Treatment:
Device: TEE probe
As-needed TEE
Other group
Description:
The TEE probe is placed only in situations where a surgeon requires information that can only be obtained by ultrasound imaging of the heart.
Treatment:
Device: TEE probe

Trial contacts and locations

1

Loading...

Central trial contact

Emily MacKay, DO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems